NCT05847803

Brief Summary

a cross-sectional survey of nurses' perception of patient monitoring in the ICUs

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 5, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2023

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 8, 2023

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2023

Completed
Last Updated

May 8, 2023

Status Verified

January 1, 2023

Enrollment Period

3 months

First QC Date

April 5, 2023

Last Update Submit

May 5, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • clinical requirements of patient monitoring in ICUs

    Assessed using a web-based 36-item survey questionnaire Patient Monitoring in the Intensive Care Unit

    12 months of working

  • Work-related flow in ICUs

    Assessed using the Work-related Flow inventory (WOLF)

    12 months of working

Interventions

No intervention, questionnaire survey

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

registered nurses in the ICUs

You may qualify if:

  • registered nurses in the ICUs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SAHZhejiangU

Hangzhou, 310009, China

RECRUITING

Study Officials

  • Wen Gao, PhD

    SAHZU

    STUDY CHAIR

Central Study Contacts

Wen Gao, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2023

First Posted

May 8, 2023

Study Start

February 5, 2023

Primary Completion

April 30, 2023

Study Completion

May 15, 2023

Last Updated

May 8, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations